New‐onset pemphigus foliaceus following SARS‐CoV‐2 infection and unmasking multiple sclerosis: A case report

New‐onset pemphigus foliaceus following SARS‐CoV‐2 infection and unmasking multiple sclerosis: A case report

Abstract Development of pemphigus foliaceus (PF) following SARS‐CoV‐2 infection has only been reported in one patient who had received Bamlanivimab and thus might be considered as a drug‐induced case of PF. Here, we reported the first case of PF arising solely after COVID infection without taking an...

Full description

Bibliographic Details
Main Authors: Fatemeh Mohaghegh, Parvaneh Hatami, Arezoo Refaghat, Mohammadjavad Mehdizadeh, Zeinab Aryanian, Nessa Aghazadeh Mohandesi, Zeinab Mohseni Afshar
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Clinical Case Reports
Subjects:
COVID‐19
multiple sclerosis
pemphigus
pemphigus foliaceus
rituximab
SARS‐Cov‐2
Online Access:https://doi.org/10.1002/ccr3.5910

Internet

https://doi.org/10.1002/ccr3.5910

Similar Items